Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$7.01 - $13.24 $448,640 - $847,360
-64,000 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$6.28 - $14.57 $401,920 - $932,480
64,000 New
64,000 $540,000
Q1 2018

May 14, 2018

SELL
$59.7 - $99.25 $597,000 - $992,500
-10,000 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$93.85 - $132.45 $938,500 - $1.32 Million
10,000
10,000 $0

Others Institutions Holding PBYI

About PUMA BIOTECHNOLOGY, INC.


  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $110M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.